FLT1 and type IV hypersensitivity disease: To determine whether there is any relevant mechanism of action in the development of DTH, and because all four VEGFR inhibitors, regardless of their nature, have been positive, we decided to silence the three VEGFR receptors, VEGFR1, VEGFR2, and VEGFR3.